Rousseau Jon B 的 Form 4/A 修正申報
修正BrightSpring Health Services, Inc.（BTSG），2024/3/18 申報
- 申報編號
- 0000908834-24-000101
- 申報時間
- 2024/3/18
- 交易日
- 2024/3/14
- 申報延遲
- 4 天
- 10b5-1 計畫
- 沒有勾選
- 原始申報日
- 2024/3/15
這份申報列了 1 筆非衍生性交易。公開市場買進合計 $30.4 萬。交易後 4 天申報。
這份修正申報取代了 0000908834-24-000094（2024/3/15 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Rousseau Jon BCIK 0001579775 | 董事、高階主管（見申報備註） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/3/14 | Common Stock | P買進取得 | +37,405 | $8.12F1 | +$303,728.6 | 1,007,236 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.95 to $8.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F2
This amendment is being filed solely to restate the amount of securities beneficially owned following the transaction reported in the original Form 4 filed on March 15, 2024, which inadvertently excluded the shares of common stock underlying restricted stock units, as further described in footnote 3 herein.
- F3
Includes 967,884 shares of the Issuer's common stock underlying restricted stock units ("RSUs") which will vest in twelve equal quarterly installments commencing on April 25, 2024. Each RSU represents a contingent right to receive one share of common stock upon settlement.
備註
Title: Chairman, President and Chief Executive Officer. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein.